Above the Clouds

Director del Programa

70e8baa1-3579-4057-9798-419e57fcb0f8_edi

Director del Programa

Perrone%25252C%252520Sergio_edited_edite
Screen Shot 2021-02-13 at 11.37.49.png
Contact us

Thanks for submitting!

Videos de la 5ta conferencia internacional 7-12 de Diciembre 2020

Heart Failure and Pulmonary Hypertension Management in the Polypharmacy and Device Era 

Heart Failure Review 2020

JOHN MC MURRAY

New Trials in Heart Failure.Where are we at the end of 2020

DAVID BARAN

Cardiogenic Shock

thumbnail_JMcM photoc ESC1.jpg
thumbnail_Baran_David_MD_SCS_5x7_edited.

JOHN CLELAND

Iron Deficiency in Heart Failure

 

MILTON PACKER

Quadruple Therapy as the new standard of care in heart failure with reduced EF

66a90d91-6142-4ba4-83c6-f6de7a80129e.jpg
Milton.Packer.Radcliffe.jpeg

 JOSEPH ROGERS

VAD-Destination Therapy or Bridge?

 

BUD FRAZIER

Ventricular Assist Devices. Present and future

thumbnail_Frazier smiling-2.jpg
Chiefs.Rogers.03_PREFERRED.jpg

PILAR ESCRIBANO

pre and post capillary pulmonary hypertension. upfront therapy?

 

STEFAN ANKER 

Drug and devices in the treatment of hfpef. new options

Pilar Escribano
Stefan_D._Anker.png

ROBERT MENTZ

With arnis and sglt2, how can we manage polipharmacy in hf?

MARCELO DI CARLI

How imaging change the treatment paradigm in cardiomyopathies

Richard krasuski

support in pulmonary hypertension in advanced right heart failure

 Carlos morillo 

End stage hf patients keep need to keep or remove CRT-d? 

thumbnail_dcri_dscf1453.jpg
Dicarli, Marcelo.jpeg
Richard A. Krasuski
thumbnail_CMorillo%20closed_edited.jpg
Lic. Sofia Barbagelata

Cordinatora Academica

Lic. Sofia Barbagelata